Continued Topline Momentum with Revenue of $65.7 million, Up Sequentially and Year-over-Year Gross Profit of $30.7 million, with Margin Expanding by 220 bps Sequentially and 125 bps Year-over-Year to ...
Use these Linux commands to quickly search and find anything from the Linux terminal, without digging through folders in a GUI file manager.
22h
Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
BroADen Phase 1b trial in atopic dermatitis (AD) patients, with data to be reported in December 2025 Initiated KT-621 BROADEN2 Phase 2b trial in AD KT-621 BREADTH Phase 2b trial in asthma on track to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback